SCHEMBL6158319

SCHEMBL6158319

CS(=O)(=O)O[C@H]1CC(=O)N(Cc2ccc(Oc3ccccc3)cc2)[C@H]1Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 6/20 0.44
HCRTR2 O43614 6/20 0.44
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
PTPN1 P18031 1/20 0.40
CCR5 P51681 3/20 0.38
MMP1 P03956 2/20 0.38
MMP3 P08254 2/20 0.38
MMP9 P14780 2/20 0.38
ADAMTS4 O75173 1/20 0.36
MMP2 P08253 1/20 0.36
MMP7 P09237 1/20 0.36
MMP8 P22894 1/20 0.36
MMP13 P45452 1/20 0.36
MMP14 P50281 1/20 0.36
ADAM17 P78536 1/20 0.36
ADAMTS5 Q9UNA0 1/20 0.36
TSHR P16473 1/20 0.36
CNR2 P34972 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6161630 1.00 HCRTR1 (0.44) HCRTR1HCRTR2MEN1KMT2APTPN1
SCHEMBL6161638 1.00 HCRTR1 (0.44) HCRTR1HCRTR2MEN1KMT2APTPN1
SCHEMBL6158791 0.90 HCRTR1 (0.45) HCRTR1HCRTR2MEN1KMT2APTPN1
SCHEMBL6158802 0.90 HCRTR1 (0.45) HCRTR1HCRTR2MEN1KMT2APTPN1
SCHEMBL6158797 0.90 HCRTR1 (0.45) HCRTR1HCRTR2MEN1KMT2APTPN1
SCHEMBL6157346 0.88 HCRTR1 (0.44) HCRTR1HCRTR2PTPN1CCR5
SCHEMBL6157341 0.88 HCRTR1 (0.44) HCRTR1HCRTR2PTPN1CCR5
SCHEMBL6157349 0.88 HCRTR1 (0.44) HCRTR1HCRTR2PTPN1CCR5
SCHEMBL6158413 0.87 HCRTR1 (0.42) HCRTR1HCRTR2MEN1KMT2APTPN1
SCHEMBL6158401 0.87 HCRTR1 (0.42) HCRTR1HCRTR2MEN1KMT2APTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078253-A1 Thiol compounds, their production and use TST, QSOX1, SULT1E1 HCRTR1 1949/4885HCRTR2 1842/4885MEN1 3957/4885
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 HCRTR1 1930/4885HCRTR2 1754/4885MEN1 3906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.